Nautilus Biotechnology, Inc.
NAUT
$0.758
$0.03474.80%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 31.00M | 31.38M | 31.64M | 30.40M | 28.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 81.48M | 81.50M | 81.47M | 79.70M | 76.15M |
| Operating Income | -81.48M | -81.50M | -81.47M | -79.70M | -76.15M |
| Income Before Tax | -70.78M | -70.21M | -69.64M | -67.44M | -63.68M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -70.78 | -70.21 | -69.64 | -67.44 | -63.68 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -70.78M | -70.21M | -69.64M | -67.44M | -63.68M |
| EBIT | -81.48M | -81.50M | -81.47M | -79.70M | -76.15M |
| EBITDA | -79.50M | -79.40M | -79.42M | -77.72M | -74.30M |
| EPS Basic | -0.56 | -0.56 | -0.56 | -0.54 | -0.51 |
| Normalized Basic EPS | -0.37 | -0.36 | -0.36 | -0.35 | -0.33 |
| EPS Diluted | -0.56 | -0.56 | -0.56 | -0.54 | -0.51 |
| Normalized Diluted EPS | -0.37 | -0.36 | -0.36 | -0.35 | -0.33 |
| Average Basic Shares Outstanding | 501.70M | 500.89M | 500.37M | 499.66M | 499.11M |
| Average Diluted Shares Outstanding | 501.70M | 500.89M | 500.37M | 499.66M | 499.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |